Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.

Add item related to this paper

  • MiniManuscript ID
    1966
  • Pubmed ID
    15679715